Associated Papers
Geographical Distribution of E-cadherin Germline Mutations in the Context of Diffuse Gastric Cancer: A Systematic Review.
Corso G et al.
Cancers, 2021
33809393 (PubMed )
Supplement: cancers-13-01269-s001.pdf
Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice.
Guilford P et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2010
Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria.
Brooks-Wilson AR et al.
Journal of Medical Genetics, 2004
Relationship between E-cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl-2 expression and Ki-67 staining in diffuse-type gastric carcinoma.
Fricke E et al.
International Journal of Cancer, 2003
Genetic screening for hereditary diffuse gastric cancer.
Oliveira C et al.
Expert Review of Molecular Diagnostics, 2003
Preventive gastrectomy in patients with gastric cancer risk due to genetic alterations of the E-cadherin gene defect.
Schwarz A
Langenbeck's Archives of Surgery, 2003
Familial gastric cancer: overview and guidelines for management.
Caldas C et al.
Journal of Medical Genetics, 1999
Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer.
Richards FM et al.
Human Molecular Genetics, 1999
Identification of eleven novel tumor-associated E-cadherin mutations. Mutations in brief no. 215. Online.
Becker KF et al.
Human Mutation, 1999
Select a paper to view details